Benzodiazepine receptor binding

Farde L, Pauli S, Litton JE, et al PET-determination of benzodiazepine receptor binding in studies on alcoholism. EXS 71 143—153, 1994... 

Miller LG, Greenblatt DJ, Barnhill JG, et ah Benzodiazepine receptor binding of tri-azolobenzodiazepines in vivo increased receptor number with low-dose alprazolam. J Neurochem 49 1595-1601, 1987... 

Malizia, AL, Cunningham, VJ, Bell, CJ, Liddle, PF, Jones, T and Nutt, DJ (1998) Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder preliminary results from a quantitative PET study. Arch. Gen. Psychiatry 55 715-720. 

MacDonald GA, Frey KA, AgranofT BW, Mi-noshima S, Koeppe RA, Kuhl DE, Shulkin BL, Lucey MR Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy. Hepatology 1998,26 277-282. 

Kunig, G Leenders, K. L Sanchez-Pemaute, R., Antonini, A., Vontobel, P Verhagen, A., and Gunther, I. (2000) Benzodiazepine receptor binding in Huntington s disease [nC]flumazenil uptake measured using positron. Ann. Neurol. 47,644-648. 

Rommelspacher H, Nanz C, Borbe HO, Fehske KJ, Muller WE, Wollert U. (1980). 1-Methyl-beta-carboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding. Naunyn Schmiedebergs Arch Pharmacol. 314(1) 97-100. 

CRF, depression and 2Lnxiety. Endocrinology 160 1—12. Bremner, J.D., Innis, R.B., Southwick, S.M., Staib, L., Zoghbi, S., and Charney, D.S. (2000a) Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry 157 1120—1126. 

Fahey JM, Pritchard GA, von Moltke LL, et al. The effects of ketoconazole on triazolam pharmacokinetics, pharmacodynamics and benzodiazepine receptor binding in mice. J Pharmacol Exp Ther 1998 285 271-276. 

Benes FM, Wickramasinghe R, Vincent SL, Khan Y, Todten-kopf M. 1997. Uncoupling of GABA(A) and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain. Brain Res 755(1) ... 

Benkert O. Decreased benzodiazepine receptor binding in panic disorder measured by lOMAZENIL-SPECT. A preliminary report. Eur. Arch. Psychiatry Clin. Neurosci. 1994 244 49-51. 113. 

Kaschka W, Eeistel H, Ebert D. Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT. J. Psychiatr. Res. 1995 29 427-434. 

Liuska A, Lehmusvaara A, Vainio P, Kononen M, Bergstrom 114. K, et al. Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder a fractal analysis. Mol. Psychiatry 1997 2 463-471. 

Recent analyses of a Free-Wilsontype have included the in vitro inhibitory activity of a series of heterocyclic compounds against K. pneumonia (197). Other applications of the Free-Wilson approach have included studies on the antimycobacterial activity of 4-alkyl-thiobenzanilides, the antibacterial activity of fluoronapthyridines, and the benzodiazepine receptor-binding ability of some non-benzodi-apzepine compounds such as 3-X-imidazo-[l,2-6]pyridazines, 2-phenylimidazo[l,2-o ]pyri-dines,2-(alkoxycarbony)imidazo[2,l-p]benzo-thiazoles, and 2-arylquinolones(198-200). 

Watt 62), one of the earlier researchers to recognize the potential of African plants in improving mental health, reported the use of Cotyledon orbiculata (Crassulaceae) leaves to treat epilepsy. Again, in vivo studies have demonstrated both aqueous and methanol extracts of C. orbiculata have anticonvulsant properties (moderate protection against pentylenetetrazole, bicuculline, picrotoxin and A-methyl-dl-aspartic induced seizures in mice) 63). However, the ethanolic extract did not show in vitro GABAA-benzodiazepine receptor binding activity 64). 

Witt MR. Nielsen M. Characterisation of the influence of unsaturated free fatty acids on brain GABA/ benzodiazepine receptor binding in vitro. J Neurochem 1994 62 1432-1439. 

Ainsworth AM, Chicarelli-Robinson MI, Copp BR, Fauth U, Hylands PJ, Holloway JA, Fatif M, O Beime GB, Porter N, Renno DV, Richards M, Robinson N, Xenovulene A. A novel GABA-benzodiazepine receptor binding compound produced by Acremonium strictum. J Antibiot 48 568-573, 1995. 

Ghose AK, Crippen GM. Modeling the benzodiazepine receptor binding site by the general three-dimensional structure-directed quantitative structure-activity relationship method REMOTEDISC. Mol Pharmacol 1990 37 725-734. 

Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder a fractal analysis. Mol Psychiatry 1997 2 463 71. 

---